Skip to content
OpenCapital
Get started

Lantern Pharma LTRN Q4 2024 Annual earnings

Reported March 27, 2025 · After market close

Revenue$100.7K
EPS-$0.54Miss by $0.03
EPS estimate-$0.51

Next report

Aug 12, 2026 (In 1 week)
EPS estimate-$0.38

Versus estimates

Revenue

Q4 2024$100.7K

Diluted EPS

Q1 2026-$0.30Beat by $0.06Q4 2025-$0.36Beat by $0.10Q3 2025-$0.39Beat by $0.07Q2 2025-$0.40Beat by $0.13Q1 2025-$0.42Beat by $0.07
Q4 2024-$0.54Miss by $0.03

Ask the moment Lantern Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lantern Pharma report Q4 2024 earnings?
Lantern Pharma (LTRN) reported Q4 2024 earnings on March 27, 2025 after market close.
What were Lantern Pharma's Q4 2024 revenue and EPS?
Lantern Pharma reported revenue of $100.7K and eps of $-0.54 for Q4 2024.
Did Lantern Pharma beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.51 by $0.03.
Where can I find Lantern Pharma's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-000926) directly on SEC EDGAR. The filing index links above go to sec.gov.